Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination

Detalles Bibliográficos
Autores principales: Fagni, Filippo, Schmidt, Katja, Bohr, Daniela, Valor-Méndez, Larissa, Hartmann, Fabian, Tascilar, Koray, Manger, Karin, Manger, Bernhard, Kleyer, Arnd, Simon, David, Schett, Georg, Harrer, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121106/
https://www.ncbi.nlm.nih.gov/pubmed/35589333
http://dx.doi.org/10.1136/rmdopen-2022-002323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121106/
https://www.ncbi.nlm.nih.gov/pubmed/35589333
http://dx.doi.org/10.1136/rmdopen-2022-002323

Ejemplares similares